Exclusive

Publication

Byline

Singapore Clinical Trial: A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Esophageal Cancer: KEYMAKER-U06 Substudy 06E

Singapore, April 3 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination Wi... Read More


Singapore Clinical Trial: A Phase I/II, Open-label, Multicenter Study of ALE.P03 (Claudin-1 Targeted Antibody-drug Conjugate) as a Monotherapy in Adult Patients with Selected Advanced or Metastatic CLDN1+ Solid Tumors

Singapore, April 3 -- The Health Sciences Authority received information related to the study titled 'A Phase I/II, Open-label, Multicenter Study of ALE.P03 (Claudin-1 Targeted Antibody-drug Conjugate... Read More


Singapore Clinical Trial: A randomised, double-blind, placebo-controlled trial with an open-label extension to assess the pharmacokinetics, safety, and efficacy of empagliflozin tablets in paediatric patients with chronic kidney disease (EMPA-KIDNEY® Kids)

Singapore, April 3 -- The Health Sciences Authority received information related to the study titled 'A randomised, double-blind, placebo-controlled trial with an open-label extension to assess the ph... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-Masked, Active-Controlled Trial of a Single Intravitreal Injection of 4D-150 in Adults with Macular Neovascularization Secondary to Age-Related Macular Degeneration (4FRONT-2)

Singapore, April 3 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Masked, Active-Controlled Trial of a Single Intravitreal Injection o... Read More


Singapore Clinical Trial: A Phase 1 Study of a Selective AKT1 E17K Allosteric Inhibitor, ATV-1601, in Patients with Advanced Solid Tumors

Singapore, April 3 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 Study of a Selective AKT1 E17K Allosteric Inhibitor, ATV-1601, in Patients with Advanced... Read More


Singapore Clinical Trial: EASi-PROTKT™ - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with type 2 diabetes, hypertension and established cardiovascular disease

Singapore, April 3 -- The Health Sciences Authority received information related to the study titled 'EASi-PROTKT™ - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate ... Read More


Quote of the Day by Franz Kafka On Life: "Anyone who keeps the ability to see beauty never grows old in Their Life"; Check Meaning & More

India, April 3 -- Quote of the Day by Franz Kafka On Life: The timeless words of Franz Kafka continue to resonate across generations. His quote, "Anyone who keeps the ability to see beauty never ... Read More


Ranveer Singh steps out for NMACC gala amid Dhurandhar 2 success, fans say he deserves every bit of the praise

India, April 3 -- Ranveer Singh is basking in the success of his last two releases, Dhurandhar and its sequel, Dhurandhar The Revenge. The first film shattered expectations and set the box office on f... Read More


Jos Buttler in awe of Vaibhav Suryavanshi; reminds Rajasthan Royals of 'don't get him too excited' before GT vs RR clash

New Delhi, April 3 -- In a light-hearted conversation with Rajasthan Royals manager Romi Bhinder and Suryavanshi, Buttler said on face, "I said the best player I've ever seen. I said don't get him too... Read More


Clinical Trial: Communication Intervention to Improve Influenza Vaccination Rates Among Elderly in Can Tho

U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT07508189) titled 'Communication Intervention to Improve Influenza Vaccination Rates Among Elderly in Can Tho'... Read More